Jin Long Miao

Direttore/Membro del Consiglio presso Jumpcan Pharmaceutical Co. Ltd.

65 anni

Health Technology

Profilo

Jin Long Miao is currently a Member-Supervisory Board & Manager at Jumpcan Pharmaceutical Co. Ltd.
Previously, he worked as a Member-Supervisory Board at Hubei Jumpcan Pharmaceutical Co., Ltd.

Posizioni attive di Jin Long Miao

Società	Posizione	Inizio
Jumpcan Pharmaceutical Co. Ltd. Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million.	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Jin Long Miao

Precedenti posizioni note di Jin Long Miao

Società	Posizione	Fine
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	Direttore/Membro del Consiglio	20/04/2019

Vedi nel dettaglio l'esperienza di Jin Long Miao

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jin Long Miao

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	Health Technology

Aziende private	1
Jumpcan Pharmaceutical Co. Ltd. Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million.	Health Technology